Early Onset of SARS-COV-2 Antibodies after First Dose of BNT162b2: Correlation with Age, Gender and BMI

Background: The first goal of the study was to analyse the antibody titre 21 days after the first dose of the BNT162b2 vaccine in a group of 252 healthcare workers (HCW). The second goal was to analyse how the antibody titre changes in correlation with age, gender and body mass index (BMI). Methods:...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellini, Raul, Venuti, Aldo, Pimpinelli, Fulvia, Abril, Elva, Blandino, Giovanni, Campo, Flaminia, Conti, Laura, De Virgilio, Armando, De Marco, Federico, Di Domenico, Enea Gino, Di Bella, Ornella, Di Martino, Simona, Ensoli, Fabrizio, Giannarelli, Diana, Mandoj, Chiara, Manciocco, Valentina, Marchesi, Paolo, Mazzola, Francesco, Moretto, Silvia, Petruzzi, Gerardo, Petrone, Fabrizio, Pichi, Barbara, Pontone, Martina, Zocchi, Jacopo, Vidiri, Antonello, Vujovic, Branka, Piaggio, Giulia, Morrone, Aldo, Ciliberto, Gennaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310011/
https://www.ncbi.nlm.nih.gov/pubmed/34206312
http://dx.doi.org/10.3390/vaccines9070685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310011/
https://www.ncbi.nlm.nih.gov/pubmed/34206312
http://dx.doi.org/10.3390/vaccines9070685

Ejemplares similares